FDA approves new painkiller designed to avoid opioid addiction risk
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller
Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...
BioSpace19 小时
FDA Approves Vertex’s Journavx as First New Pain Drug in Decades
The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...
FDA approves painkiller designed to eliminate addiction risk associated with opioids
Prescriptions have fallen sharply in the last decade and the current wave of the opioid epidemic is mainly due to illicit ...
The Washington Post19 天
Billed as nonaddictive, new pain pill could soon win FDA approval
If the company does eventually win approval for a longer-term pain treatment, financial analysts say, its portfolio of painkillers in ... reactions that was even lower than it was for those ...